Back to search

Belgium· BE-AMP-SAM003692-00

Chloramphenicol BePB 1 %

A chloramphenicol product containing chloramphenicol, registered in Belgium by BePharBel Manufacturing. The same ATC class is registered in 2 of our 19 countries.

ATC D06AX02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedChloramphenicol BePB 1 %ATCD06AX02REGISTER NO.BE-AMP-SAM003692-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Chloramphenicol is registered in 2 of 19 countries.

Countries holding a registration under ATC D06AX02 (chloramphenicol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose

Chloramphenicol · ATC D06AX02

2 / 19 countries

  • Belgiumprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Chloramphenicol
Manufacturer
BePharBel Manufacturing
Country
Belgium (BE)
ATC code
D06AX02
ATC class
Chloramphenicol
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0105999
  • be_apb
    0702944

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Chloramphenicol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chloramphenicol products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Chloramphenicol Agepha, Halomycetin
  • Bulgaria · Хлорнитромицин
  • Germany · Chloramphenicol Smartpractice Europe, Posifenicol C
  • Denmark · Kloramfenikol ”santen”, Kloramfenikol Dak
  • Estonia · Oftan Akvakol
  • Spain · Oftalmolosa Cusí Cloramfenicol
  • Finland · Oftan Akvakol, Oftan Chlora
  • United Kingdom (Northern Ireland) · Almus Infected Eye, Almus Infected Eyes
  • Greece · Chloramphenicol (Χωρίσ Συντηρητικό) Pharmathen, Ursa-Fenol
  • Ireland · Chloromycetin Redidrops, Minims
  • Iceland · Oftan Chlora
  • Italy · Chemicetina, Flogocyn
  • Latvia · Oftan Akvakol
  • Malta · Posifenicol C
  • Netherlands · Chlooramfenicol Minims Bausch Health Ireland Limited, Chlooramfenicol Teva
  • Norway · Kloramfenikol Evolan, Kloramfenikol Evolan Pharma
  • Poland · Detreomycyna, Detreomycyna Chema-Elektromet
  • Portugal · Clorocil, Micetinoftalmina
  • Romania · Cloramfenicol Arena
  • Sweden · Kloramfenikol, Kloramfenikol Santen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fda1623c-a03e-4140-ab1c-bdedfc878192
GET /v1/drugs/fda1623c-a03e-4140-ab1c-bdedfc878192?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye ointment",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Chloramphenicol BePB 1 %",
  "name_fr": "Chloramphenicol BePB 1 %",
  "name_nl": "Chloramphenicol BePB 1 %",
  "amp_code": "SAM003692-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "10.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Chloramphenicol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Chloramphenicol",
  "authorisation_numbers": [
    "BE003692"
  ]
}

See everything about chloramphenicol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.